BiotechTube
Sepragen

Sepragen

Hayward, United States· Est.
sepragen.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.7M

Overview

Sepragen is a private, established player in the bioprocess equipment sector, providing chromatography systems, columns, and resins based on its proprietary Radial Flow technology. The company serves pharmaceutical and biotechnology companies, enabling faster and more cost-effective purification of biologics and vaccines, as evidenced by its role in supporting COVID-19 vaccine development. With a global installation footprint and a focus on cGMP automation, Sepragen operates as a revenue-generating equipment and consumables supplier within the broader drug delivery and manufacturing ecosystem.

Drug Delivery

Technology Platform

Proprietary Radial Flow Chromatography technology enabling high-flow, low-pressure purification for biologics, vaccines, and diagnostics. Platform includes automated systems (QuantaSep®), columns (SuperFlo®), and resins (Sepraflo®).

Funding History

2
Total raised:$1.7M
Debt$1.2M
Grant$500K

Opportunities

Growth is driven by the expanding biologics and vaccine markets, particularly the industry shift towards continuous bioprocessing and single-use technologies where Sepragen's systems are positioned.
The need for cost-effective and rapid purification in biosimilar development and pandemic response presents significant demand.

Risk Factors

Heavy reliance on its niche Radial Flow technology faces competition from large, well-funded players offering conventional axial flow systems and alternative purification methods.
Revenue is subject to the capital expenditure cycles of the biopharma industry, which can be volatile.

Competitive Landscape

Operates in a competitive market dominated by large life science tools companies like Cytiva, Thermo Fisher, and Sartorius. Sepragen differentiates through its specialized radial flow technology, which offers claimed advantages in speed, footprint, and cost for specific purification applications.

More companies in Biologics / Biosimilars →More companies in United States →